Comments
Loading...
Edge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Metsera Stock Price, Quotes and Forecasts | NASDAQ:MTSR | Benzinga
Explore Metsera stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MTSR.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Metsera (MTSR) stock?
You can purchase shares of Metsera (NASDAQ:MTSR) through any online brokerage.
Who are Metsera (MTSR) competitors?
Other companies in Metsera’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX) and Protagonist Therapeutics (NASDAQ:PTGX).
What is the forecast, or price target, for Metsera (MTSR) stock?
Metsera has a consensus price target of $47.00.
What is the current price for Metsera (MTSR)?
The stock price for Metsera (NASDAQ: MTSR) is $27.9556 last updated March 4, 2025 at 10:44 AM EST.
Does Metsera (MTSR) pay a dividend?
There are no upcoming dividends for Metsera.
When is Metsera (NASDAQ:MTSR) reporting earnings?
Metsera does not have any upcoming earnings scheduled.
Is Metsera (MTSR) going to split?
There is no upcoming split for Metsera.
What sector and industry does Metsera (MTSR) operate in?
Metsera is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.